General Monod Bio licenses AI-designed protein technologies to SignalChem Biotech for custom discovery assaysBy Healthcare Propulsion StaffAugust 27, 20260 Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc., today…
